In addition, treatment with RK-33 and CX4945 in PCa cells, which are inhibitors of DDX3X and CSNK2A1 respectively, produced the same results in vitro and in vivo (Figs. 6A–J and S8C–G). This evidence concerns the gene CSNK2A1 and posterior cortical atrophy.